• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical Characteristics of Adult Hemophagocytic Lymphohistiocytosis in the Emergency Department.急诊科成人噬血细胞性淋巴组织细胞增生症的临床特征
Int J Gen Med. 2021 Aug 20;14:4687-4694. doi: 10.2147/IJGM.S326270. eCollection 2021.
2
A Three-Step Screening Procedure for Early Identification of Children at High Risk of Hemophagocytic Lymphohistiocytosis.三步筛查程序,早期识别噬血细胞性淋巴组织细胞增生症高危患儿。
J Clin Immunol. 2023 Jul;43(5):989-998. doi: 10.1007/s10875-023-01458-y. Epub 2023 Mar 6.
3
[Relationship between marked hyperferritinemia and hemophagocytic lymphohistiocytosis].[显著高铁蛋白血症与噬血细胞性淋巴组织细胞增生症之间的关系]
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Oct 18;53(5):921-927. doi: 10.19723/j.issn.1671-167X.2021.05.018.
4
Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detection.不明原因发热成人患者噬血细胞性淋巴组织细胞增生症的风险:一种新的评分系统对早期检测的临床应用价值
Hematol Oncol. 2017 Dec;35(4):835-844. doi: 10.1002/hon.2333. Epub 2016 Jul 28.
5
Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults.台湾地区成年人噬血细胞性淋巴组织细胞增生症相关感染性疾病的病因、临床症状和结局。
J Microbiol Immunol Infect. 2011 Jun;44(3):191-7. doi: 10.1016/j.jmii.2011.01.027. Epub 2011 Jan 20.
6
Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue.登革热感染合并噬血细胞性淋巴组织细胞增生症:180 例重症登革热患者的经验。
Clin Infect Dis. 2020 May 23;70(11):2247-2255. doi: 10.1093/cid/ciz499.
7
[Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].儿童Epstein-Barr病毒相关噬血细胞性淋巴组织细胞增生症的临床分析及随访研究
Zhonghua Er Ke Za Zhi. 2010 Feb;48(2):121-6.
8
Clinical Profile, Treatment, and Outcome of Patients with Secondary Hemophagocytic Lymphohistiocytosis in Critically Ill Patients: A Prospective Observational Study.危重症患者继发性噬血细胞性淋巴组织细胞增生症的临床特征、治疗及转归:一项前瞻性观察研究
Indian J Crit Care Med. 2022 May;26(5):564-567. doi: 10.5005/jp-journals-10071-24136.
9
Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.小儿噬血细胞性淋巴组织细胞增生症的疗效分析。
J Formos Med Assoc. 2021 Jan;120(1 Pt 1):172-179. doi: 10.1016/j.jfma.2020.03.025. Epub 2020 Apr 16.
10
Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults.成人移植相关性噬血细胞性淋巴组织细胞增生症的特征和预测因素。
Int J Hematol. 2021 May;113(5):693-702. doi: 10.1007/s12185-020-03067-6. Epub 2021 Jan 1.

引用本文的文献

1
Hemophagocytic Syndrome: A Serious Complication in Non-Hodgkin Lymphoma.噬血细胞综合征:非霍奇金淋巴瘤的一种严重并发症。
Cureus. 2025 Apr 4;17(4):e81705. doi: 10.7759/cureus.81705. eCollection 2025 Apr.
2
Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Study in a Belgian Teaching Hospital.成人噬血细胞性淋巴组织细胞增生症:比利时一家教学医院的回顾性研究
Int J Gen Med. 2022 Nov 8;15:8111-8120. doi: 10.2147/IJGM.S388880. eCollection 2022.
3
Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症中的细胞因子风暴和靶向治疗。
Immunol Res. 2022 Oct;70(5):566-577. doi: 10.1007/s12026-022-09285-w. Epub 2022 Jul 11.

本文引用的文献

1
Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies.成人复发性/难治性噬血细胞性淋巴组织细胞增生症的临床管理:当前策略与新兴疗法综述
Ther Clin Risk Manag. 2021 Apr 14;17:293-304. doi: 10.2147/TCRM.S195538. eCollection 2021.
2
The prognostic role of plasma fibrinogen in adult secondary hemophagocytic lymphohistiocytosis.血浆纤维蛋白原在成人继发性噬血细胞性淋巴组织细胞增生症中的预后作用。
Orphanet J Rare Dis. 2020 Nov 25;15(1):332. doi: 10.1186/s13023-020-01622-2.
3
Serum hydroxybutyrate dehydrogenase as an early predictive marker of the severity of acute pancreatitis: a retrospective study.血清羟基丁酸脱氢酶作为急性胰腺炎严重程度的早期预测标志物:一项回顾性研究。
BMC Gastroenterol. 2020 Nov 20;20(1):393. doi: 10.1186/s12876-020-01521-7.
4
Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis.乳酸脱氢酶水平可预测 2019 冠状病毒病(COVID-19)的严重程度和死亡率:一项汇总分析。
Am J Emerg Med. 2020 Sep;38(9):1722-1726. doi: 10.1016/j.ajem.2020.05.073. Epub 2020 May 27.
5
Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.危重症噬血细胞性淋巴组织细胞增生症:HLH-2004 标准和 HScore 的诊断可靠性。
Crit Care. 2020 May 24;24(1):244. doi: 10.1186/s13054-020-02941-3.
6
[Clinical analysis of 81 adult patients with hemophagocytic lymphohistiocytosis].81例成人噬血细胞性淋巴组织细胞增生症患者的临床分析
Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 14;41(3):248-250. doi: 10.3760/cma.j.issn.0253-2727.2020.03.011.
7
Adult haemophagocytic lymphohistiocytosis: a Review.成人噬血细胞性淋巴组织细胞增生症:综述
QJM. 2020 Jan 14. doi: 10.1093/qjmed/hcaa011.
8
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.成人噬血细胞性淋巴组织细胞增生症的治疗建议。
Blood. 2019 Jun 6;133(23):2465-2477. doi: 10.1182/blood.2018894618. Epub 2019 Apr 16.
9
Hemophagocytic Lymphohistiocytosis: Clinical Presentations and Diagnosis.噬血细胞性淋巴组织细胞增生症:临床表现与诊断。
J Allergy Clin Immunol Pract. 2019 Mar;7(3):824-832. doi: 10.1016/j.jaip.2018.11.050. Epub 2018 Dec 14.
10
Prognostic Factors and Outcomes in Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-center Experience.成人继发性噬血细胞性淋巴组织细胞增生症的预后因素及结局:一项单中心经验
Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e373-e380. doi: 10.1016/j.clml.2018.06.014. Epub 2018 Jun 30.

急诊科成人噬血细胞性淋巴组织细胞增生症的临床特征

Clinical Characteristics of Adult Hemophagocytic Lymphohistiocytosis in the Emergency Department.

作者信息

Zhang Fang-Jie, Huang Guo-Qing, Li Jia, Xu Ji, Li Xiang-Min, Wang Ai-Min

机构信息

Department of Emergency Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.

出版信息

Int J Gen Med. 2021 Aug 20;14:4687-4694. doi: 10.2147/IJGM.S326270. eCollection 2021.

DOI:10.2147/IJGM.S326270
PMID:34447263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8384344/
Abstract

PURPOSE

To determine the clinical manifestations and results of adult hemophagocytic lymphohistiocytosis (HLH) patients in our emergency department.

METHODS

We retrospectively evaluated patients with HLH from 1 April 2018 to 31 December 2020. The clinical data of these patients (basic information, symptoms, vital signs, laboratory results, HLH diagnostic criteria, H Score, main treatments, outcomes) were collected.

RESULTS

Thirty-three patients (23 males and 10 females; 40.55±18.78 years) with 34 clinical episodes (one male had two clinical episodes and died during the second episode) were enrolled. Twenty-five patients were placed in a "survivor" group, and nine patients were categorized into a "deceased" group. Fever, splenomegaly, hemoglobin <90 g/L and platelet count <100×10/L most commonly met the diagnostic standard for HLH. The H Score results in the survival group and deceased group was 212.4±37.18 and 252.1±40.95, respectively. Viral infection was the most common reason for HLH, followed by immune-system disease and cancer. Laboratory tests showed that deceased-group patients had multiple-organ dysfunction. Multivariate logistic regression showed that the lactate dehydrogenase (lactate dehydrogenase) level (P = 0.039; odds ratio, 0.999) was significantly related to death.

CONCLUSION

In the emergency department, HLH should be considered for critically ill patients with fever, splenomegaly, low hemoglobin and low platelet count. The H Score might be useful to diagnose HLH quickly. In our study, 26.47% of HLH patients died in the emergency department, and patients with a significantly increased lactate dehydrogenase level had a markedly increased risk of death.

摘要

目的

确定我院急诊科成人噬血细胞性淋巴组织细胞增生症(HLH)患者的临床表现及治疗结果。

方法

回顾性评估2018年4月1日至2020年12月31日期间的HLH患者。收集这些患者的临床资料(基本信息、症状、生命体征、实验室检查结果、HLH诊断标准、H评分、主要治疗方法、治疗结果)。

结果

共纳入33例患者(男23例,女10例;年龄40.55±18.78岁),发生34次临床发作(1例男性有2次临床发作,第二次发作时死亡)。25例患者归入“存活”组,9例患者归入“死亡”组。发热、脾肿大、血红蛋白<90 g/L和血小板计数<100×10⁹/L最常符合HLH诊断标准。存活组和死亡组的H评分结果分别为212.4±37.18和252.1±40.95。病毒感染是HLH最常见的原因,其次是免疫系统疾病和癌症。实验室检查显示,死亡组患者存在多器官功能障碍。多因素logistic回归分析显示,乳酸脱氢酶水平(P = 0.039;比值比,0.999)与死亡显著相关。

结论

在急诊科,对于伴有发热、脾肿大、血红蛋白降低和血小板计数降低的危重症患者应考虑HLH。H评分可能有助于快速诊断HLH。在我们的研究中,26.47%的HLH患者在急诊科死亡,乳酸脱氢酶水平显著升高的患者死亡风险明显增加。